Buyer
CELL AND GENE THERAPY CATAPULT
The tender notices in our corpus from CELL AND GENE THERAPY CATAPULT, newest first, read from Find a Tender and Contracts Finder. Each links to its own page and to the original.
- Notices in the corpus
- 31Counted in the corpus search index when this page was read, across every stage (forecast, tender, award, contract). The index is refreshed by the corpus, so the newest notices may be missing for a while.Counted at Tue 27 Oct 2026, 00:04 GMT.
- Newest notice published
- 22 Oct 2026
- Buyer type
- OtherThe corpus’s classification from the buyer name, as supplied.
- Read the buyer’s published records, newest first.
- Separate planning, live opportunities and historical outcomes.
- Read the original lot, value basis and documents.
- Investigate relevance before authorising response work.
Which notices has this buyer published?
Open notices are live tenders and forecasts. All notices also include historical ones: awarded, closed or past their deadline.
- Multi-Column Continuous Chromatography System and Automated Viral Inactivation SystemCell & Gene Therapy Catapult · Published 22 Oct 2026CGTC are looking for the purchase and installation of a multi-column chromatography system (MCCS) and a viral inactivation hardware system with related services e.g service, repair and maintenance contract, training and consumables for our Braintree Essex site. both systems will be system applicablValue not stated in sourceCloses Tue 17 Nov 2026, 12:00 GMT
- Multi-Column Continuous Chromatography System and Automated Viral Inactivation SystemCell & Gene Therapy Catapult · Published 22 Oct 2026CGTC are looking for the purchase and installation of a multi-column chromatography system (MCCS) and a viral inactivation hardware system with related services e.g service, repair and maintenance contract, training and consumables for our Braintree Essex site. both systems will be system applicablValue not stated in sourceCloses Tue 17 Nov 2026, 12:00 GMT
- Computer Systems Validation ContractorCell & Gene Therapy Catapult · Published 29 Sep 2026CGT Catapult has entered into a strategic collaboration agreement with Ena Biologics for the development and manufacture of biologics. This collaboration for the Braintree site requires significant qualification and validation of systems, equipment, and processes. The objective of this collaboratiValue not stated in sourceHistorical · Awarded
- Gases SMICCell & Gene Therapy Catapult · Published 29 Sep 2026Cell and Gene Therapy Catapult (CGTC) are looking for a supplier to provide a reliable, compliant and cost-effective supply of industrial gases, together with associated delivery, management, digital tracking, reporting, training and support services. The Contract shall include the tank rental, suppValue not stated in sourceHistorical · Awarded
- Cloud-Based Scientific Literature Content and Management PlatformCell & Gene Therapy Catapult · Published 21 Sep 2026The CGTC requires a cloud-based scientific literature content and management platform (‘the platform’). The platform aims to provide all Cell and Gene Therapy Catapult staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory conteValue not stated in sourceHistorical · Awarded
- Cleanroom Mop Supply or Part-Rental, Processing and MaintenanceCell & Gene Therapy Catapult · Published 21 Sep 2026The selected supplier will supply (either by purchase or part-rental) and maintain cleanroom mops to be utilised in CGTC’s cleaning operations at SMIC (which is currently carried out by a third-party contractor on behalf of CGTC). This service will be compliant with GMP, Good Laboratory Practice (GLValue not stated in sourceHistorical · Open
- Premarket Engagement for Downstream Manufacturing Cleanroom BraintreeCell & Gene Therapy Catapult · Published 28 Aug 2026Pre-market engagement is being undertaken for the proposed design and build of a new Grade C downstream manufacturing cleanroom (Module B) at the Braintree Manufacturing Innovation Centre (BMIC). The engagement will test the market’s capability to deliver the complete design, construction, commissioValue not stated in sourceForecast · Planning
- Premarket Multi Column Chromatography System and Viral Inactivation Hardware SystemCell & Gene Therapy Catapult · Published 27 Aug 2026CGT Catapult is undertaking Preliminary Market Engagement to understand the market capability for an Automated Viral Inactivation System and Multi Column Chromatography System. We are seeking supplier feedback on available solutions, technical capability, lead times and any further information requiValue not stated in sourceForecast · Planning
- Cloud-Based Scientific Literature Content and Management PlatformCell & Gene Therapy Catapult · Published 23 Jul 2026The Cell and Gene Therapy Catapult is requesting a cloud-based scientific literature content and management platform. The platform should provide all staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory content. The contract wValue not stated in sourceHistorical · Open
- Environmental, Health and Safety Management SystemCell & Gene Therapy Catapult · Published 16 Jun 2026Value not stated in sourceHistorical · Cancelled
- Data Migration Engineer Cell & Gene Therapy Catapult · Published 15 Apr 2026The role of the Data Migration Engineer is to provide expert input to the ERP implementation team for a 12-month project, split in two distinct 6-month work packages. The successful candidate will be responsible for planning, executing, and validating data migration activities from legacy systems toValue not stated in sourceHistorical · Awarded
- Braintree Security ServiceCell & Gene Therapy Catapult · Published 15 Apr 2026Value not stated in sourceHistorical · Cancelled
- Report Writing and Data AnalysisCELL AND GENE THERAPY CATAPULT · London · Published 5 Nov 2024Report Writing and Data Analysis Description: The ATTC programme is seeking for organisations and/or independent consultants to provide report writing and data analysis services in relation the outputs of milestones within the 7 workstreams of the Phase 2 Delivery plan. The overall aim is to manValue not stated in sourceHistorical · Contract
- Collaborator Feedback and InsightsCELL AND GENE THERAPY CATAPULT · Published 20 Nov 2023Cell Therapy Catapult Ltd is seeking through this Open tender process to contract with a specialist provider of customer surveys / customer feedback and with experience of research and technology organisations in the healthcare industries. The supplier will be responsible for collecting and analysin£320,000Estimated value stated in the noticeHistorical · Open
- Premarket Engagement for the Future Purchase of a Liquid Chromatography-Mass SpectrometerCELL AND GENE THERAPY CATAPULT · Published 10 Nov 2023The Cell and Gene Therapy Catapult ("CGTC") is interested in understanding the market, and whether vendors can supply our requirements. CGTC is seeking a supplier to provide a Liquid Chromatography-Mass Spectrometer instrument (LCMS), as well as the installation and training of the equValue not stated in sourceHistorical · Closed
- Premarket Engagement for the Future Purchase of a Fluorescence Activated Cell Sorter (FACS) Instrument and Associated Post Installation ServicesCELL AND GENE THERAPY CATAPULT · Published 22 Aug 2023CGTC is seeking a supplier to provide a Fluorescence Activated Cell Sorter (FACS) instrument, as well as the installation and training of the equipment. The contract will include parts, service and maintenance on necessary items and the supplier will ensure that there are warranties in place on theValue not stated in sourceHistorical · Closed
- Premarket Engagement Specification for Transmission electron cryomicroscopy assay (Cryo-TEM Assay)CELL AND GENE THERAPY CATAPULT · Published 22 Aug 2023CGTC is seeking a supplier to perform a Cryo-TEM assay on our samples and analysis. CGTC want a supplier that can Quantify the quality of AAV samples with ns-TEM and cryo-TEM analyses, as well as assess overall morphology, including integrity, impurities, filled empty capsid ratio, genome length, anValue not stated in sourceHistorical · Closed
- Premarket Engagement Specification for Custom column packing service (cGMP and non-cGMP grade)CELL AND GENE THERAPY CATAPULT · Published 22 Aug 2023CGTC is seeking a supplier to provide custom column packing for chromatography. Before commencing a formal tender process, the CGTC are keen to seek market information from organisations that may have an interest or expertise in this field. The information provided will be used to help inform and sValue not stated in sourceHistorical · Closed
- Office Cleaning Contract at CGTC LondonCELL AND GENE THERAPY CATAPULT · Published 20 Jun 2023Office Cleaning Contract at CGTC LondonValue not stated in sourceHistorical · Awarded
- Operational Excellence ProgrammeCELL AND GENE THERAPY CATAPULT · Published 7 Mar 2023Cell Therapy Catapult Ltd were seeking a Bidder to provide the Services for an Operational Excellence Programme. The Operational Excellence initiative is being established to ensure that the business can function in a high performing high-quality state across all main business streams: Stevenage MaValue not stated in sourceHistorical · Awarded
- Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated virusesCELL AND GENE THERAPY CATAPULT · Published 10 Oct 2022Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subj£180,000Estimated value stated in the noticeHistorical · Open
- Purchase of Multiple Laboratory Equipment from Framework agreement General Laboratory Equipment and Associated Post Installation Services LAB5061 LU Lot 11CELL AND GENE THERAPY CATAPULT · 9 regions · Published 6 Oct 2022We are using London Universities Purchasing Consortium (LUPC), Framework agreement: General Laboratory Equipment and Associated Post Installation Services LAB5061 LU, Lot 11 'One Stop Shop' to select a new service provider for multiple laboratory equipment, as well as the installation of t£137,359Estimated value stated in the noticeHistorical · Contract
- Consultants for Laboratory fit-out to the principles Universal DesignCELL AND GENE THERAPY CATAPULT · Published 13 Sep 2022CGTC are looking for consultants to design and develop a laboratory for advanced therapy medicinal products (ATMPs) that meets the principles of Universal Design (UD) and can be scaled-out across the sector. If you are interested in this opportunity please access the procurement document through our£275,000Estimated value stated in the noticeHistorical · Open
- Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated virusesCELL AND GENE THERAPY CATAPULT · Published 13 Sep 2022Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The saValue not stated in sourceHistorical · Awarded
- Training needs analysis of NHS staff involved in the use and delivery of Advanced Therapy Medicinal Products (ATMPs)CELL AND GENE THERAPY CATAPULT · South East · Published 25 Aug 2022A training needs analysis of NHS staff involved across the ATMP supply chain, from procurement of starting materials through to receipt, preparation and administration of the final product, whether that be a part of clinical trial or delivery of a licensed product, is desired in order to develop app£60,000Estimated value stated in the noticeHistorical · Contract
What has this buyer published most recently?
This preview follows the current page’s record order. It is a sample, not a complete history or a forecast.
- 01
Multi-Column Continuous Chromatography System and Automated Viral Inactivation System
Value not stated in source
- 02
Multi-Column Continuous Chromatography System and Automated Viral Inactivation System
Value not stated in source
- 03
- 04
- 05
Cloud-Based Scientific Literature Content and Management Platform
Value not stated in source
How should you check a record before using it?
Follow its notice page to the original publication, then read the current document and value basis.
A published amount may describe a contract, lot or framework ceiling. The wording beside each record states the basis supplied by the source.
Publications: Find a Tender and Contracts Finder.
- Open the linked tender page and its original publication, where recorded.
- Separate publication, award and response dates.
- Read the value basis; a framework ceiling is not money spent.
- Use the named organisation; do not merge a group parent by assumption.
How much time should you allow to review this page?
Multiply the visible record count by your own review time. Follow-up documents are extra work.
Plan this page’s review
25 records on this page × your minutes per record.
Five minutes is an illustration. Later pages and linked documents are additional work.
Estimated review time125 minutesSource: Your inputs and this page · Visible record count
125 minminutes
- First record5
- Remaining records on this page120
Planning estimate for 25 records read at Tue 27 Oct 2026, 00:04 GMT; not a measured average or a total for the organisation.
What should you investigate first?
Check the notice’s stage and scope before treating it as available work.
- Record01
Open one relevant notice
Keep its identifier and original publication together. - Context02
Separate invitation from outcome
Planning and award notices are not current invitations. - Evidence03
Read the current documents
Follow scope, lots and updates; resolve missing information through the buyer. - Decision04
Record why it matters
Keep facts separate from eligibility or future-demand assumptions. - Action05
Name a useful follow-up
Decide whether preparation work is justified.
An editorial review sequence, not a buyer timetable or predicted cycle.
What can you safely conclude from these records?
Use the facts each record states. A page of notices or awards does not establish market share, a win rate or future demand.
Review the recorded limitations below. Missing data stays missing, and organisations are linked only when the corpus supplies a page key.
- The corpus and this page are bounded views of published records.
- No organisation-wide spend or awarded-value total is calculated here.
- A named buyer link is not evidence of a wider group relationship.
- Past records do not establish the next opportunity’s date or value.
Where can you investigate next?
Use the guides to resolve the notice stage, framework or evidence question.
| Next record or guide | Purpose |
|---|---|
| Search Contracts Finder records | Understand the next part of the bid |
| Separate frameworks from contracts | Understand the next part of the bid |
| Check the invitation’s stage | Understand the next part of the bid |
| Check security evidence | Understand the next part of the bid |
The next decision needs a record someone can check.
What is the useful next action?
Open a relevant notice and establish whether there is work your team should investigate.
Keep the source, uncertainty and decision together.
Explore current and past tenders →- Locate a relevant published notice.
- Follow original documents and the stage.
- Resolve evidence and delivery questions.
- Keep a specific action and its reasons.
What are the limits of this record?
- Notices are linked to this buyer by a slug made from the buyer name on each notice. A notice that writes the name differently may be under another buyer, or none.
- Buyer type is the corpus's classification from the buyer name, not an official category.
Where was this record read?
- Buyer
- cell-and-gene-therapy-catapult
- Read at
- Tue 27 Oct 2026, 00:04 GMT
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.